People in the News
James Glover will retire from Beckman Coulter on June 30, the company said last week.
In an SEC filing the company said that Glover, chief financial officer, will retain his current pay and benefits for 18 months after his retirement date, that he will receive a pro-rated bonus for 2006, and his stock options will vest early, on his retirement date.
Teranode appointed three new managers last week. They are Murthy Srinivas, president of product and platform development; John Ohrn, vice president sales; and Yoram Lapid, vice president, sales and support.
Srinivas was the founder and vice president of engineering at Consera Software, which was acquired by Hewlett Packard. Prior to working at Consera, he had positions at Banyan Systems, Atria, and Microsoft.
Ohrn was director of sales and support at Accelrys before joining Teranode.
Lapid was a director of design and consulting services at Cadence Design Systems. He was also vice president of engineering at Solidium Systems and Philsar Semiconductors.
New Product Watch
Affymetrix this week launched nine tiling array products for five different organisms. The company said that researchers can use the tiling arrays to map sites of DNA-protein interaction in chromatin immunoprecipitation (ChIP)-on-chip experiments, discover new RNA transcripts, or investigate global epigenomic changes like methylation or acetylation.
For humans, Affy launched its Human Tiling 2.0R Array Set, a seven-array set designed for ChIP-on-chip experiments, and a Human Promoter 1.0R Array, an array with more than 4.6 million probes tiled to interrogate more than 25,500 human promoter regions.
For mouse, Affy released its Mouse Tiling 2.0R Array Set, a seven-array set for ChIP-on-chip experiments, and its Mouse Promoter 1.0R Array, an array with more than 4.6 million probes tiled to interrogate more than 28,000 mouse promoter regions.
Affy said that tiling array supporting products, such as its GeneChip WT Double-Stranded DNA Terminal Labeling Kit, Tiling Analysis Software, Integrated Genome Browser, and Chromatin Immunoprecipitation Assay Protocol are also available.
Nanogen last week launched its NGen CFTR Analyte Specific Reagents, which are designed to genotype 23 wild type and mutation sequences that are associated with cystic fibrosis for CF carrier screening.
The company said that assays using the NGen CFTR ASRs can be used in clinical diagnostics.